XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-based Compensation (Tables)
3 Months Ended
Sep. 30, 2022
Share-based Compensation  
Summary of non-vested restricted stock awards

Weighted

Average Grant-date

Aggregate

(In thousands, except for weighted average price data)

    

Awards

    

Fair Value

    

Intrinsic Value

Non-vested at June 30, 2022

 

1,355

$

5.28

Granted

 

 

Vested

 

(549)

 

5.46

$

317

Forfeited

 

(22)

 

5.00

Non-vested at September 30, 2022

 

784

$

5.17

Schedule of allocation of share-based compensation

Three Months Ended

September 30, 

(In thousands)

    

2022

    

2021

Selling, general and administrative expenses

$

1,444

$

2,697

Research and development expenses

 

28

 

95

Cost of sales

 

107

 

226

Total

$

1,579

$

3,018

Tax benefit at statutory rate

$

355

$

679